Cargando…

Heterogeneity in PD-L1 expression in malignant peritoneal mesothelioma with systemic or intraperitoneal chemotherapy

Programmed death-ligand 1 (PD-L1) expression has been described in patients with malignant peritoneal mesothelioma (MPM), but treatment strategies utilising immune checkpoint inhibition are yet to be defined. Here, we examine levels of PD-L1 expression in MPM patients treated with systemic and/or in...

Descripción completa

Detalles Bibliográficos
Autores principales:	White, Michael G., Schulte, Jefree J., Xue, Lai, Berger, Yaniv, Schuitevoerder, Darryl, Vining, Charles C., Kindler, Hedy L., Husain, Aliya, Turaga, Kiran K., Eng, Oliver S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Brief Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7851380/ https://www.ncbi.nlm.nih.gov/pubmed/33100328 http://dx.doi.org/10.1038/s41416-020-01130-x

Ejemplares similares

Response to Comment on “Heterogeneity in PD-L1 expression in malignant peritoneal mesothelioma with systemic or intraperitoneal chemotherapy”
por: White, Michael G., et al.
Publicado: (2020)

Update on the pathologic diagnosis of malignant mesothelioma
por: Schulte, Jefree J., et al.
Publicado: (2020)

Comment on “Heterogeneity in PD-L1 expression in malignant peritoneal mesothelioma with systemic or intraperitoneal chemotherapy”
por: Yang, Haitang, et al.
Publicado: (2020)

Application of immunohistochemistry in diagnosis and management of malignant mesothelioma
por: Chapel, David B., et al.
Publicado: (2020)

Tumor volume is an independent predictor of survival in patients with malignant pleural mesothelioma
por: Kircheva, Diana Y, et al.
Publicado: (2015)

Systemic Treatments for Mesothelioma: Standard and Novel
por: Kindler, Hedy Lee
Publicado: (2008)

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal peritoneal metastases: Where do we stand?
por: Witmer, Hunter D. D., et al.
Publicado: (2022)

Virtual Surgical Fellowship Recruitment During COVID-19 and Its Implications for Resident/Fellow Recruitment in the Future
por: Vining, Charles C., et al.
Publicado: (2020)

Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) for the treatment of malignant mesothelioma
por: Giger-Pabst, Urs, et al.
Publicado: (2018)

Role of laparoscopy in patients with peritoneal metastases considered for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC)
por: Jayakrishnan, Thejus T, et al.
Publicado: (2014)

Outcomes of multicystic peritoneal mesothelioma treatment with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
por: Zahid, A, et al.
Publicado: (2020)

Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for peritoneal mesothelioma: patient selection and special considerations
por: Enomoto, Laura M, et al.
Publicado: (2019)

Sphingosine Kinase 1 Is Required for Mesothelioma Cell Proliferation: Role of Histone Acetylation
por: Kalari, Satish, et al.
Publicado: (2012)

Robotic Distal Pancreatectomy and Splenectomy for an Intrapancreatic Hepatocellular Carcinoma: A Case Report and Review of the Literature
por: Vining, Charles C., et al.
Publicado: (2020)

MET and PI3K/mTOR as a Potential Combinatorial Therapeutic Target in Malignant Pleural Mesothelioma
por: Kanteti, Rajani, et al.
Publicado: (2014)

Unique fractal evaluation and therapeutic implications of mitochondrial morphology in malignant mesothelioma
por: Lennon, Frances E., et al.
Publicado: (2016)

Adjuvant Bidirectional Chemotherapy with Intraperitoneal Pemetrexed Combined with Intravenous Cisplatin for Diffuse Malignant Peritoneal Mesothelioma
por: Bijelic, Lana, et al.
Publicado: (2012)

Germline Variants Incidentally Detected via Tumor-Only Genomic Profiling of Patients With Mesothelioma
por: Mitchell, Owen D., et al.
Publicado: (2023)

A phase 2 randomized, double-blind, placebo-controlled study of tremelimumab for second and third line treatment in patients with unresectable pleural or peritoneal mesothelioma
por: Krug, Lee, et al.
Publicado: (2013)

Quantitative X-ray Computed Tomography Peritoneography in Malignant Peritoneal Mesothelioma Patients Receiving Intraperitoneal Chemotherapy
por: Leinwand, Joshua C., et al.
Publicado: (2013)

Role of protein kinase C β and vascular endothelial growth factor receptor in malignant pleural mesothelioma: Therapeutic implications and the usefulness of Caenorhabditis elegans model organism
por: Loganathan, Sivakumar, et al.
Publicado: (2011)

Peritoneal mesothelioma.
por: Kealey, W. D., et al.
Publicado: (1993)

Peritoneal mesothelioma.
por: Churg, J
Publicado: (1974)

Peritoneal mesothelioma
por: Greenbaum, Alissa, et al.
Publicado: (2020)

EPHA2 mutations with oncogenic characteristics in squamous cell lung cancer and malignant pleural mesothelioma
por: Tan, Yi-Hung Carol, et al.
Publicado: (2019)

Multicystic peritoneal mesothelioma
por: Tentes, Antonios-Apostolos, et al.
Publicado: (2012)

Malignant Peritoneal Mesothelioma
por: Fukunaga, Tomohiko, et al.
Publicado: (2022)

PI3 Kinase Pathway and MET Inhibition is Efficacious in Malignant Pleural Mesothelioma
por: Kanteti, Rajani, et al.
Publicado: (2016)

Peritoneal Malignant Psammomatous Mesothelioma
por: Pusiol, Teresa, et al.
Publicado: (2010)

Primary Peritoneal Desmoplastic Mesothelioma
por: Malla, Sundeep, et al.
Publicado: (2020)

Surgical Treatment of Peritoneal Carcinomatosis from Gastric Cancer
por: Turaga, Kiran K., et al.
Publicado: (2012)

The Impact of COVID-19-Related Delays on Surgical Management of Peritoneal Surface Malignancies
por: Sood, Divya, et al.
Publicado: (2022)

Utilisation of a thoracic oncology database to capture radiological and pathological images for evaluation of response to chemotherapy in patients with malignant pleural mesothelioma
por: Carey, George B, et al.
Publicado: (2012)

Intraperitoneal paclitaxel for patients with primary malignant peritoneal mesothelioma: a phase I/II dose escalation and safety study—INTERACT MESO
por: van Kooten, Job P, et al.
Publicado: (2022)

Benign peritoneal cystic mesothelioma mimicking peritoneal tuberculosis
por: Soltani, Chayma, et al.
Publicado: (2022)

Phase II Prospective, Open-Label Randomized Controlled Trial Comparing Standard of Care Chemotherapy With and Without Sequential Cytoreductive Interventions for Patients with Oligometastatic Foregut Adenocarcinoma and Undetectable Circulating Tumor Deoxyribose Nucleic Acid (ctDNA) Levels
por: Dhiman, Ankit, et al.
Publicado: (2022)

Induction of mesothelioma by intraperitoneal injections of ferric saccharate in male Wistar rats.
por: Okada, S., et al.
Publicado: (1989)

Extensive intrathoracic and intraperitoneal splenosis mimicking mesothelioma: a case report
por: Föh, Bandik, et al.
Publicado: (2022)

Pharmacokinetics of Intraperitoneal Vancomycin and Amikacin in Automated Peritoneal Dialysis Patients With Peritonitis
por: Falbo dos Reis, Pâmela, et al.
Publicado: (2021)

Life Expectancy in Pleural and Peritoneal Mesothelioma
por: Shavelle, Robert, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_62m4immre7q7sshndujilf6cm5